aMayo Clinic College of Medicine, Rochester, Minnesota, USA
bDivision of Pediatric Infectious Diseases, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota, USA
cDivision of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA
dDepartment of Surgery, Mayo Clinic, Rochester, Minnesota, USA
eCenter for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, USA
fSeattle Children's Research Institute, Seattle, Washington, USA
gDivision of Infectious Diseases, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA
hWayne State University and Detroit Medical Center, Detroit, Michigan, USA
Citation Hasassri ME, Boyce TG, Norgan AP, Cunningham SA, Jeraldo PR, Weissman SJ, Patel R, Banerjee R, Pogue JM (Commentator), Kaye KS (Commentator). 2016. Correction for Hasassri et al., An immunocompromised child with bloodstream infection caused by two Escherichia coli strains, one harboring NDM-5 and the other harboring OXA-48-like carbapenemase. Antimicrob Agents Chemother 60:5108. doi:10.1128/AAC.01338-16.
Roles
Jason M Pogue: (Commentator)
Keith S Kaye: (Commentator)